RXDX - Prometheus Biosciences EPS misses by $0.12 beats on revenue November, 12 2021 08:38 AM Prometheus Biosciences Inc. Prometheus Biosciences (NASDAQ:RXDX): Q3 GAAP EPS of -$0.70 misses by $0.12. Revenue of $1.01M (+180.6% Y/Y) beats by $0.68M. Press Release For further details see: Prometheus Biosciences EPS misses by $0.12, beats on revenue